Evidence and Research-Based Lyme Treatment Recommendations
News from the Board
ILADS Campaign Highlights Importance of Doctor-Patient Relationship in Treating Chronic Diseases
Bethesda, MD, December 9, 2021 – The International Lyme and Associated Diseases Society (ILADS) is running a powerful public awareness campaign to highlight the importance of doctor-patient relationships in the treatment of Lyme and other chronic diseases. The campaign debuted this week on a jumbotron in New York City’s Times Square.
The jumbotron video highlights the challenges doctors face from bureaucratic institutions when trying to treat patients. The video sends viewers to the ILADS.ORG website for more information. (Click to view video).
ILADS supports a doctor’s freedom to treat and a patient’s right to choose the best treatment options available, without bureaucratic interference. A doctor’s primary duty is to put the patient first. Outside interference restricts a physician’s ability to provide optimum care.
“We want to restore real healthcare for our patients and allow doctors to prescribe the best possible treatments without interference from insurance companies and other bureaucracies,” said Dr. Steven J. Bock, president of the ILADS Board of Directors.
The jumbotron is anything but invisible. The giant video screen is 29 feet tall and 56 feet across and is strategically positioned at 1500 Broadway on the corner of 44th Street and 7th Avenue in New York City. The spot will run 5 times per hour for 36 days. It is estimated that 1.6 million people pass through Times Square each day. The spot will remain in place during the December holidays and New Year’s Eve celebration for bonus exposure.
Chevy Chase, MD – March 26, 2020 – The International Lyme and Associated Diseases Society (ILADS) is launching a new registry and crowd-solving platform, One Health Lyme, which will provide valuable resources to healthcare providers who are treating patients with Lyme and related diseases. In the planning stages for a while, the launch of the One Health Lyme initiative is being pushed forward expeditiously in response to the COVID-19 pandemic. One Health Lyme will give Lyme healthcare providers a unique opportunity to track and communicate the impact of COVID-19 on this specific group of patients. The unique immunological lesions of these patients will help us gain insights of general importance in the battle against COVID-19. Similar to initiatives operated by specialty societies that treat autoimmune diseases, this project will collect data from physicians about patient experiences and treatments. The goal is to create a vast repository of information about lyme…Read More >